A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma

Clinical trial NCT01432951 · COMPLETED

Trial details

NCT number: NCT01432951
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma, Malignant

Start date: 2011-11-01
Primary completion: 2013-01-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.